Related Experiment Video
Updated: Sep 19, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
Natural experiments of herpes zoster vaccination: Quantifying the implied vaccine effectiveness against dementia
Mika Kivimäki1, Philipp Frank2, Gill Livingston2
1Faculty of Brain Sciences, University College London, London, UK; Clinicum, University of Helsinki, Helsinki, Finland.
Abstract:
Recent natural experiments conducted in Wales, Australia, and Canada found a lower risk of all-cause dementia among individuals eligible for live-attenuated herpes zoster (shingles) vaccination than among those who were ineligible, but the extent to which these findings were attributable to vaccination has rarely been quantified. We estimated the reduction in dementia risk among vaccinated individuals implied by the published findings, accounting for incomplete vaccination among eligible individuals and vaccination among ineligible individuals. Combining the reported eligibility effects with differences in vaccine uptake yielded implied reductions in dementia risk among vaccinees of 18% (95% confidence interval -0-35) in Wales, 177% (28-301) in Australia, and 84% (18-219) and 111% (15-303) in the two Canadian analyses. Thus, two estimates exceeded the theoretical maximum effectiveness of 100%, while the third non-Welsh estimate was also implausibly large; even under very high assumed vaccine effectiveness, explaining these findings would require underlying dementia risks among individuals vaccinated because of eligibility to be 1.7-2.3 times higher than in vaccine-ineligible populations, an unlikely scenario. The implied reductions in mild cognitive impairment and dementia-related mortality associated with vaccination were also large, at 41% and 56%, respectively. If vaccination reduced dementia risk by effects of the magnitude implied by these natural experiments, a decline might be expected in population-level dementia incidence following implementation of herpes zoster vaccination programmes; however, no corresponding decline was observed in national data from the UK, Australia, or Canada. In conclusion, the reported natural experiments on herpes zoster vaccination and dementia cannot be considered strong evidence of a clinically meaningful effect; their implied vaccination effects are internally inconsistent and, in some cases, impossible or biologically implausible, highlighting the need for independent replication.
Related Concept Videos
Chickenpox
Herpes
What is an Experiment?
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Bias in Epidemiological Studies

